Director's blog
院長日記

One of the three arrows of anti-aging treatment: Adipose-derived stem cell culture supernatant treatment reservation sold out

武本 重毅

Among the three anti-aging arrows that we at JURAKU Internal Medicine Clinic started this year,

the most recent one is

the infusion therapy of human-derived mesenchymal stem cell culture supernatant.

Regarding the adipose-derived stem cells, we will end the current handling (total of 114 cells so far).

 

I explained the reason why I chose adipose-derived stem cells first

among human-derived mesenchymal stem cells

in my previous director’s diary (February 3, 5, 9, 2023).

Reason 1 for choosing adipose stem cell culture supernatant

Reason 2 for choosing adipose stem cell culture supernatant

Reason 3 for choosing adipose stem cell culture supernatant

 

It was particularly important that

extracellular secretory vesicles (EVs) secreted from adipose tissue contain eNAMPT,

an NMN (nicotinamide mononucleotide)-producing enzyme.

 

As one of the three arrows of anti-aging,

we will continue to provide treatments

using human mesenchymal stem cell-derived culture supernatant.

In the future, treatment using Wharton’s jelly,

that is, the culture supernatant of umbilical cord-derived stem cells, will become mainstream.

It contains 10 times more exosomes than fat-derived, so you can expect more effects.

 

 

Author:

武本 重毅

聚楽内科クリニックの院長、医学博士。